GeneDx has completed the acquisition of Fabric Genomics, a US-based company focused on AI-driven human genomic interpretation ...

Eye health company Bausch + Lomb has received the CE Mark approval in Europe for its LuxLife full range of vision intraocular ...

HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...

MedTech reveals that Europeans are generally willing to share their healthcare data in exchange for personalised treatment ...

BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) ...

Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM ...

Firefly Neuroscience has completed the acquisition of Evoke Neuroscience, a developer of technologies aimed at assessing ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to GE HealthCare's Aurora nuclear medicine system and ...

Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas.

Zimmer Biomet has adjusted its 2025 earnings forecast to $7.90-$8.10 per share, down from previous estimates falling between ...